| Nanog mRNA positive | ||||||
| Clinicopathological |
| n | Case | Number rate% | Parameter χ2-value | PP-value |
| Age (ys) | ≤60 | 57 | 13 | (22.81) | 35.7277 | 0.0001 |
| >60 | 30 | 27 | (90.00) |
|
| |
| Gender | Male | 45 | 25 | (55.56) | 1.4014 | 0.2365 |
| Female | 42 | 18 | (42.86) |
|
| |
| Tumor size (cm) | ≤5 | 35 | 12 | (34.29) | 0.8605 | 0.3536 |
| >5 | 52 | 23 | (44.23) |
|
| |
| TNM Staging | I + II | 41 | 15 | (36.59) | 3.4579 | 0.0630 |
| III + IV | 46 | 26 | (56.52) |
|
| |
| Differentiation Grade | medium and well differentiated | 53 | 16 | (30.19) | 15.6144 | 0.0001 |
| Low undifferentiated | 34 | 25 | (75.53) |
|
| |
| Infiltration depth | T1, T2 | 41 | 12 | (29.27) | 6.5452 | 0.0105 |
| T3, T4 | 46 | 26 | (56.62) |
|
| |
| Lymph node metastasis | Yes | 42 | 23 | (54.76) | 7.1314 | 0.0076 |
| No | 45 | 12 | (26.67) |
|
| |